Michael M. Morrissey

Michael M. Morrissey

Chair of the BoardatExelixis· In proxies 2019–2025

Pay in FY2025+161% from the year before · Exelixis stock +52.3% the same year

Michael M. Morrissey was paid $33.2M in FY2025 (Jan), up 161%. Exelixis stock rose 52.3% that year.

Pay$100 in the stock at the end of FY21 → $149
Pay is from the Summary Compensation Table of each Exelixis proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Vera TherapeuticsPublic company · 3 yr
    • Chair of the Board2023 – Present · 3 yrNo stock prices for these years
  2. ExelixisPublic company · 7 yr
    • President and Chief Executive Officer2019 – Present · 7 yrStock in role +117%
  3. Vera Therapeutics, Inc. (Chair), serving on the AuditPublic company
    • Director? – PresentNo stock prices for these years
  4. XWPharma Ltd.Public company · 3 yr
    • Director2020 – 2023 · 3 yrNo stock prices for these years
  5. CERo Therapeutics, Inc.Public company · Less than 1 yr
    • Director2022 – 2022 · Less than 1 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?